<p>Clonogenic assays were performed where cells were treated with DMSO, 0.3μM AZD8010/AZD4547, 0.1μM gefitinib, or both in the presence or absence of a TGF- receptor I (TGFRI) small molecule inhibitor: SB525334 (1μM). After 2 weeks of incubation, colony growth was measured. This assay was performed in a panel of cell lines and is shown here for <b>A.</b> UMSCC25 <b>B.</b> 584-A2 <b>C.</b> UMSCC8 and <b>D.</b> HN31. <b>E.</b> Representative images of the experiment performed with UMSCC8 cells in C. *denotes a p-value <0.05; **denotes a p-value <0.006; *** and ****denotes a p-value <0.0001.</p
<p>A, The endogenous protein levels of TGF-β type I receptor (TβRI) and type II receptor (TβRII) in ...
<p><b>A</b>, Human growth factor antibody array showing overall low growth factor release by pediatr...
<p><b>(A)</b> HL-60 cell proliferation in the presence of increasing concentrations of TGFβ alone (b...
<p>(A) A549 cells were treated with DMSO, different concentrations of TGFβ-1 (0–10 ng/mL; white bars...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
<p><b>A</b>) KGN cells were treated without (CTL) or with TGFα (10 ng/ml) in DMEM supplied with incr...
<p>(A) The indicated cell lines were treated with 2.5 ng/ml TGFβ, 100 nM rapamycin, or TGFβ + rapamy...
<p>(A) Phosphorylation of EGFR and ERK1/2 was suppressed by an EGFR inhibitor, AG1478. Each value sh...
<p>(A–C) TGF-β receptor kinase inhibitors stimulate the growth of NRP-152 cells. NRP-152 cells plate...
<p>(A) Smad2/3 nuclear localization (Ai, green) and <i>CXCR4</i> expression (Aii) in TGF-β-treated 6...
<p>KGN cells were treated without (Control) or with TGFα (10 ng/ml) and/or kinase inhibitors for 24 ...
<p>(A) HaCaT cells were treated with TG 0.5 µM for 1 h at 37°C following by incubation at 37°C for 4...
<p>(A) LN229, U251 and HS683 cells were left untreated or were treated for 24 h with erlotinib and s...
<p>(A) A83-01, inhibitor of the TGFβ receptor kinase, was assayed at 0.1, 0.3 and 0.5 μM in duplicat...
<p>A CyQUANT Direct Cell Proliferation Assay was performed on UMSCC25 cells treated with a concentra...
<p>A, The endogenous protein levels of TGF-β type I receptor (TβRI) and type II receptor (TβRII) in ...
<p><b>A</b>, Human growth factor antibody array showing overall low growth factor release by pediatr...
<p><b>(A)</b> HL-60 cell proliferation in the presence of increasing concentrations of TGFβ alone (b...
<p>(A) A549 cells were treated with DMSO, different concentrations of TGFβ-1 (0–10 ng/mL; white bars...
<p>(a) Phase-contrast micrographs of NHU cell cultures at confluence following growth for 6 days in ...
<p><b>A</b>) KGN cells were treated without (CTL) or with TGFα (10 ng/ml) in DMEM supplied with incr...
<p>(A) The indicated cell lines were treated with 2.5 ng/ml TGFβ, 100 nM rapamycin, or TGFβ + rapamy...
<p>(A) Phosphorylation of EGFR and ERK1/2 was suppressed by an EGFR inhibitor, AG1478. Each value sh...
<p>(A–C) TGF-β receptor kinase inhibitors stimulate the growth of NRP-152 cells. NRP-152 cells plate...
<p>(A) Smad2/3 nuclear localization (Ai, green) and <i>CXCR4</i> expression (Aii) in TGF-β-treated 6...
<p>KGN cells were treated without (Control) or with TGFα (10 ng/ml) and/or kinase inhibitors for 24 ...
<p>(A) HaCaT cells were treated with TG 0.5 µM for 1 h at 37°C following by incubation at 37°C for 4...
<p>(A) LN229, U251 and HS683 cells were left untreated or were treated for 24 h with erlotinib and s...
<p>(A) A83-01, inhibitor of the TGFβ receptor kinase, was assayed at 0.1, 0.3 and 0.5 μM in duplicat...
<p>A CyQUANT Direct Cell Proliferation Assay was performed on UMSCC25 cells treated with a concentra...
<p>A, The endogenous protein levels of TGF-β type I receptor (TβRI) and type II receptor (TβRII) in ...
<p><b>A</b>, Human growth factor antibody array showing overall low growth factor release by pediatr...
<p><b>(A)</b> HL-60 cell proliferation in the presence of increasing concentrations of TGFβ alone (b...